Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging-Reference-Cited by-同舟云学术

Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging

Published:2021-10-13 Issue:1 Volume:47 Page:152-160
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Polikoff Adam,Wessner Corinne E.,Balasubramanya Rashmi,Dulka Susan,Liu Ji-Bin,Machado Priscilla,Savsani Esika,Lyshchik Andrej,Shaw Colette M.,Eisenbrey John R.^ORCID

Funder

Foundation for the National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-021-03298-z.pdf

Reference25 articles.

1. McGlynn KA, Petrick JL, El‐Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021;73(S1):4-13. doi:https://doi.org/https://doi.org/10.1002/hep.31288

2. Rawla P, Sunkara T, Muralidharan P, Raj JP. Update in global trends and aetiology of hepatocellular carcinoma. Contemp Oncol. 2018;22(3):141-150. doi:https://doi.org/10.5114/wo.2018.78941

3. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterology. 2008;134(6):1752-1763. doi:https://doi.org/10.1053/j.gastro.2008.02.090

4. Makary MS, Khandpur U, Cloyd JM, Mumtaz K, Dowell JD. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies. Cancers. 2020;12(7). doi:https://doi.org/10.3390/cancers12071914

5. Heckman JT, deVera MB, Marsh JW, et al. Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation. Ann Surg Oncol. 2008;15(11):3169-3177. doi:https://doi.org/10.1245/s10434-008-0071-3

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D-CEUS/MRI–CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation;European Radiology;2024-07-11

2. LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features;Abdominal Radiology;2024-04-11

3. Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial;Radiology;2023-10-01